XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
OPERATING ACTIVITIES    
Net income including noncontrolling interest $ 1,524.7 $ 1,652.4
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation 493.8 473.7
Amortization 226.5 226.2
Deferred income taxes (57.1) (149.7)
Share-based compensation expense 109.5 109.5
Pension and postretirement plan contributions (67.1) (43.7)
Pension and postretirement plan expense (income), net 10.4 11.5
Restructuring charges, net of cash paid (12.5) (11.7)
Sale of global surgical solutions business 1.1 (382.7)
Other, net 20.4 17.7
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable (150.3) (109.3)
Inventories (37.6) (163.6)
Other assets 34.1 (41.1)
Accounts payable (47.8) 277.7
Other liabilities (185.6) 180.3
Cash provided by operating activities 1,862.5 2,047.2
INVESTING ACTIVITIES    
Capital expenditures (716.2) (634.8)
Property and other assets sold 46.4 3.3
Acquisitions and investments in affiliates, net of cash acquired (0.5) (56.4)
Divestiture of businesses, net of cash divested (14.9) 889.7
Other, net (43.8) (8.1)
Cash (used for) provided by investing activities (729.0) 193.7
FINANCING ACTIVITIES    
Net issuances of commercial paper and notes payable 1.1 3.3
Long-term debt borrowings 1,019.0  
Long-term debt repayments (674.2) (630.4)
Reacquired shares (374.6) (983.7)
Dividends paid (564.4) (502.9)
Exercise of employee stock options 182.0 232.8
Hedge settlements   (0.6)
Other, net (10.6) (2.5)
Cash used for financing activities (421.7) (1,884.0)
Effect of exchange rate changes on cash and cash equivalents (12.8) (15.3)
Increase in cash and cash equivalents 699.0 341.6
Cash and cash equivalents, beginning of period 1,256.8 919.5
Cash and cash equivalents, end of period $ 1,955.8 $ 1,261.1